These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7017244)

  • 21. A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation.
    Novick AC; Braun WE; Steinmuller D; Buszta C; Greenstreet R; Kiser W
    Transplantation; 1983 Feb; 35(2):175-9. PubMed ID: 6338636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation.
    Cantarovich D; Le Mauff B; Hourmant M; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Paineau J; Soulillou JP
    Transplantation; 1994 Jan; 57(2):198-203. PubMed ID: 8310507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM; Yang SL; Wu WZ; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations.
    MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J
    Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
    J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin.
    Thibaudin D; Alamartine E; de Filippis JP; Diab N; Laurent B; Berthoux F
    Nephrol Dial Transplant; 1998 Mar; 13(3):711-5. PubMed ID: 9550651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
    Thomas F; Mendez-Picon G; Thomas J; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithymocyte globulin in renal transplant recipients. Report of a prospective randomized controlled trial.
    Chatterjee SN
    Arch Surg; 1976 Jun; 111(6):680-3. PubMed ID: 58651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of different ATG (ATGAM) regimens on levels of rosette-forming cells (RFC), serum horse IgG (HoI), and anti-horse antibodies in kidney transplant patients.
    Satoh P; Elberg A; Davis J; Uittenbogaart C; Fine R; Hardy MA
    Transplant Proc; 1979 Jun; 11(2):1427-8. PubMed ID: 382530
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study.
    van den Hoogen MW; Kho MM; Abrahams AC; van Zuilen AD; Sanders JS; van Dijk M; Hilbrands LB; Weimar W; Hoitsma AJ
    Exp Clin Transplant; 2013 Apr; 11(2):134-41. PubMed ID: 23431996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
    Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS
    Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 38. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
    Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
    Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.
    Hourmant M; Le Mauff B; Cantarovich D; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Soulillou JP
    Transplantation; 1994 Jan; 57(2):204-7. PubMed ID: 8310508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
    Schulz T; Papapostolou G; Schenker P; Kapischke M
    Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.